Vontobel Holding Ltd. Gsk PLC Transaction History

Vontobel Holding Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$42.05 - $47.77 $166,560 - $189,216	-3,961 Reduced 14.73%	22,937 $998,000
Q1 2022 May 13, 2022	SELL	$40.23 - $47.74 $487,064 - $577,988	-12,107 Reduced 31.04%	26,898 $1.17 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $4,743 - $5,527	122 Added 0.31%	39,005 $1.72 Million
Q3 2021 Oct 29, 2021	BUY	$38.79 - $43.16 $201,863 - $224,604	5,204 Added 15.45%	38,883 $1.49 Million
Q2 2021 Aug 06, 2021	SELL	$36.52 - $41.46 $35.5 Million - $40.3 Million	-972,715 Reduced 96.65%	33,679 $1.34 Million
Q1 2021 May 11, 2021	SELL	$34.27 - $40.01 $286,874 - $334,923	-8,371 Reduced 0.82%	1,006,394 $35.9 Million
Q4 2020 Feb 12, 2021	BUY	$34.07 - $39.94 $34.6 Million - $40.5 Million	1,014,765 New	1,014,765 $37.3 Million

167K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $71.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.